DGAP-News: INJEX Pharma AG / Key word(s): Miscellaneous INJEX Pharma AG: Strategic Financial Group invests in INJEX Pharma AG 17.12.2013 / 11:11 --------------------------------------------------------------------- Corporate News: Strategic Financial Group invests in INJEX Pharma AG Berlin, December 17, 2013 - INJEX Pharma AG anounces, that Fambrinia Ltd. (Fambrinia) has taken a significant share in the Berlin based company and has become the largest shareholder in INJEX Pharma AG. Fambrinia holds the distribution rights for Injex Pharma products in Russia, Kazachstan, Azerbaijan, Belorussia and Turkmenistan. The respective contracts have been signed last Friday. The previously signed term sheet between the parties was already announced in an ad hoc news by INJEX Pharma last week. Fambrinia subscribes all newly issued ordinary shares of a 10% capital increase decided by the Executive Board and authorized by the Supervisory Board. Following this capital increase, the company's share capital rises from EUR 3,458,000.00 to EUR 3,803,800.00, divided into 3,803,800 shares at a nominal value of EUR 1.00 per share. The issue price per share is set at EUR 1.00. The new shares carry full dividend rights from 1 January 2013. The new shares will be issued in private placement without pre-emptive rights. Furthermore, Fambrinia acquires a majority of the shares currently held by MMB Medical Marketing Berlin GmbH (MMB), so far the major shareholder of INJEX Pharma AG. MMB will transfer the most of the sales proceeds as a shareholder loan to INJEX Pharma AG. The proceeds from this transaction will mainly be used to reduce the companies liabilities and to further develop its operations. Upon consummation of the transaction, Fambrinia will held 40% of INJEX Pharma shares and become be the major shareholder, followed by MMB holding 14% of the shares. 'We are very pleased having attracted Fambrinia as a strategic investor, who will provide us with growth capital as well as with valuable input for the future development for our products and applications since Fambrinia is our distributor for the huge markets in CIS countries.' commented Dr. Thomas Klaue, CEO of INJEX Pharma AG. Dr. Peter Heinrich, Chairman of the Supervisory Board, adds: 'With this transaction, the Management Board, which took office in last May, has concluded most of the necessary reorganization and restructuring of INJEX Pharma and can now focus on our operating business, mainly on the production development and the expansion of the international partner and distributor network.' For further information on INJEX Pharma AG and its subsidiaries, please refer to www.injex.com. For further questions please contact our Investor Relations team directly: INJEX Pharma AG Investor Relations-Team t: +49 89 24 41 18 - 223 f: +49 89 24 41 18 - 228 ir@injex.de INJEX Pharma AG: INJEX Pharma Aktiengesellschaft and its subsidiaries INJEX Pharma GmbH and INJEX Vertrieb Deutschland GmbH are specialized in the development, manufacturing and marketing in the medical technology segment and in the cosmetics and beauty markets. The Group's core business areas are the needle-free INJEX30 system and the product line SHIREEN in the beauty market. The main markets of the Group are North America, China, India, Russia and Europe. End of Corporate News --------------------------------------------------------------------- 17.12.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: INJEX Pharma AG Buckower Damm 114 12349 Berlin Germany Phone: +49 89 24 41 18 - 223 Fax: +49 89 24 41 18 - 499 E-mail: ir@injex.de Internet: www.injex.de ISIN: DE000A0STYL7 WKN: A0STYL Listed: Regulierter Markt in Frankfurt (General Standard) Notierung im Regulierten Markt vorgesehen / intended to be listed at Regulated Market End of News DGAP News-Service --------------------------------------------------------------------- 245122 17.12.2013
DGAP-News: INJEX Pharma AG: Strategic Financial Group
Top 10 Most Recent News Articles
D-Wave Quantum Faces Class Action Over Stock Missteps
A lawsuit has been lobbed at D-Wave Quantum Inc., and Wall Street's abuzz over it. Investors who've dabbled in NASDAQ:QBTS between February 26 and August 25, 2026 might be eligible to hop onto this class action lawsuit train. The beef is all about allegedly misleading statements concerning the company's operational outlook, and it's a familiar song and dance when a...
Continue Reading
Iranian Cyber Group Shifts Tactics, Hits U.S. Soil
A Stealthy Comeback on U.S. Turf In an era where cyber skirmishes aren’t just happening in digital ether but echoing throughout geopolitical landscapes, we have an eye-opener: Prince of Persia, that covert Iranian cyber player, has popped up stateside. Tomer Bar from Semperis has been dogging their trail for years and recently stumbled upon their latest U.S.-based...
Continue Reading
Microtubule Defects Revealed: Impacts on Cancer Treatment
Peering into the Heart of Microtubules Ever squint at a tapestry, only to find a rogue thread ruining the pattern? Well, that’s somewhat what scientists at Kanazawa University have found with microtubules, those tiny rods in our cells that usually keep it all together. Using some pretty fancy tech called high-speed atomic force microscopy, these folks peered into the...
Continue Reading
ThreatLocker Launches Global AI Awareness Campaign
Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...
Continue Reading
Better Home's Litigation Storm: Investor Alert for Stakeholders
Legal Murmurs Rock Better Home & Finance Like an old ship caught in a storm, Better Home & Finance Holding Company (NASDAQ: BETR) finds itself teetering on unstable seas. Investors got blindsided by a dramatic 28.5% drop in stock value on May 7, 2026, following revelations from the company's first-quarter earnings call that investors aren't likely to forget anytime soon....
Continue Reading
James Cahill's Centenary: Honoring a Chinese Art Pioneer
A Celebration of a Visionary in Chinese Art In the typically bustling city of Hangzhou, a quiet reverence fell at the China Academy of Art (CAA) on October 17–18, 2026. There, they marked the centenary of one of the titans of art history, James Francis Cahill. He was the kind of person who could walk into a room and change how you looked at the walls. His legacy...
Continue Reading
Frost & Sullivan Boosts China Insight with LeadLeo
Navigating China's Complex Market Landscape You've got to understand, the stakes in China are like a high-wire act—mystifying and risky, yet bountiful if you play your cards right. Frost & Sullivan's latest maneuver into China's business intel scene is basically the lifeline for navigating this increasingly convoluted market. With China surging ahead in AI, biotech, and...
Continue Reading
Rocket Companies' Earnings Preview: What's at Stake?
Anticipation Builds Around Rocket's Earnings Call It ain't every day that a company's earnings announcement stirs up interest the way Rocket Companies' (NYSE:RKT) upcoming third-quarter results have. But here we are, just days away from October 29, 2026, when leadership will lay out the cards at 4:30 p.m. ET. This announcement might just be what investors like us need to...
Continue Reading
Vertice P2P Aims to Transform Procurement Efficiency
Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...
Continue Reading
Unpacking the Sonic NEXT S13: A Toolbox Evolution
An All-in-One Solution Rolls In Listen up, gearheads and wrench-turners. Sonic Tools USA isn’t messing around with their newest release, the Sonic NEXT S13 toolbox. If you're tired of wrestling stubborn storage or losing track of your tools, this might just be what the shop ordered. Built to endure the tough grind of workshops from aviation to auto repair, the S13 is...
Continue ReadingTop 5 Most Recently Viewed Articles
Eco Wave Power Moves Ahead with Landmark Wave Energy Project
Eco Wave Power Secures Final Permit for Wave Project Eco Wave Power Global AB (NASDAQ: WAVE) is thrilled to announce that it has successfully obtained the final Nationwide Permit (NWP) from the U.S. Army Corps of Engineers for its innovative wave energy project. This groundbreaking initiative is set to take place at the Port of Los Angeles, representing a significant leap...
Continue Reading
XOMA Royalty Closes Acquisition of LAVA Therapeutics Shares
XOMA Royalty Concludes Acquisition of LAVA Therapeutics In a landmark move, XOMA Royalty Corporation (Nasdaq: XOMA) has announced the completion of its acquisition of LAVA Therapeutics N.V. (NASDAQ: LVTX). This acquisition involved the purchase of all outstanding common shares of LAVA, valued at €0.12 each, with shareholders receiving $1.04 in cash for each share as...
Continue Reading
Medical Displays Market: Unlocking Growth Opportunities Ahead
Medical Displays Market Overview The global medical displays market is on an impressive growth trajectory, with a projected valuation estimated to reach US$3.45 billion. This noteworthy surge from US$2.50 billion, which marked the market's value in 2024, is attributed to several key factors. The ongoing rise in chronic diseases, coupled with an aging population and...
Continue Reading
Jim Belushi's Farm Debuts Signature Cannabis Strains
Belushi's Farm Introduces Exciting Cannabis Strains Jim Belushi, the acclaimed cannabis advocate and founder of Belushi's Farm, is thrilled to announce a partnership with Wondergrove, enhancing their reach by introducing signature strains across Ohio. This initiative is a part of a broader movement towards sustainable, high-quality cannabis cultivation that emphasizes...
Continue Reading
TRX Gold's Spectacular Year-End Performance Fuels Growth Plans
Strong Year-End Results from TRX Gold TRX Gold Corporation (TSX: TRX) has recently shared its impressive fourth quarter results alongside key highlights from the fiscal year ending August 31, 2025. Demonstrating a solid financial performance, the Company achieved remarkable milestones that include record gold production and substantial revenues, setting the stage for an...
Continue Reading